{
    "xml": "<topic id=\"PHP78986\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/prostin-e2-vaginal-gel\" basename=\"prostin-e2-vaginal-gel\" title=\"Prostin E2 vaginal gel\">\n<title>Prostin E2<tm tmtype=\"reg\"/> vaginal gel</title>\n<topic id=\"PHP79449\" outputclass=\"indicationsAndDose\" rev=\"1.18\" parent=\"/clinical-medicinal-product-information/prostin-e2-vaginal-gel\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Induction of labour</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By vagina</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;mg, inserted high into the posterior fornix (avoid administration into the cervical canal), followed by 1&#8211;2&#8239;mg after 6&#8239;hours (max. per dose 3&#8239;mg) if required.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Induction of labour (unfavourable primigravida)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By vagina</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult female\">\n<p>Adult (female)</p>\n<p>2&#8239;mg, inserted high into the posterior fornix (avoid administration into the cervical canal), followed by 1&#8211;2&#8239;mg (max. per dose 4&#8239;mg) if required.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>\n<i>Prostin E2 Vaginal Gel</i> and <i>Vaginal Tablets</i> are not bioequivalent.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP78986",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/prostin-e2-vaginal-gel",
    "basename": "prostin-e2-vaginal-gel",
    "title": "Prostin E2 vaginal gel",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Induction of labour",
                        "html": "Induction of labour"
                    }
                ],
                "specificity": {
                    "routes": [
                        "vagina"
                    ],
                    "textContent": "By vagina",
                    "html": "By vagina"
                },
                "adult": [
                    {
                        "textContent": "1 mg, inserted high into the posterior fornix (avoid administration into the cervical canal), followed by 1&#8211;2 mg after 6 hours (max. per dose 3 mg) if required.",
                        "html": "<p>1&#8239;mg, inserted high into the posterior fornix (avoid administration into the cervical canal), followed by 1&#8211;2&#8239;mg after 6&#8239;hours (max. per dose 3&#8239;mg) if required.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Induction of labour (unfavourable primigravida)",
                        "html": "Induction of labour (unfavourable primigravida)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "vagina"
                    ],
                    "textContent": "By vagina",
                    "html": "By vagina"
                },
                "adult female": [
                    {
                        "textContent": "2 mg, inserted high into the posterior fornix (avoid administration into the cervical canal), followed by 1&#8211;2 mg (max. per dose 4 mg) if required.",
                        "html": "<p>2&#8239;mg, inserted high into the posterior fornix (avoid administration into the cervical canal), followed by 1&#8211;2&#8239;mg (max. per dose 4&#8239;mg) if required.</p>",
                        "ageGroup": "adult (female)"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Prostin E2 Vaginal Gel and Vaginal Tablets are not bioequivalent.",
                "html": "<p>\n<i>Prostin E2 Vaginal Gel</i> and <i>Vaginal Tablets</i> are not bioequivalent.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}